West Pharmaceutical Services, Inc. (WST) Stock Analysis
A live, multi-source view of West Pharmaceutical Services, Inc. (WST): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies.
Sector: Healthcare · Industry: Medical Instruments & Supplies · United States · 10,800 employees · westpharma.com
Key statistics · as of 2026-09-06
As of 2026-09-06, West Pharmaceutical Services, Inc. (WST) had a market capitalization of $23.93B, a trailing P/E of 43.5 (forward 34.1), a dividend yield of 0.26% and a beta of 1.14; the shares traded in a 52-week range of $223.83 – $386.00 (34.3% over the year).
- Market cap
- $23.93B
- Enterprise value
- $23.81B
- Trailing P/E
- 43.5
- Forward P/E
- 34.1
- PEG ratio
- 2.67
- Price / book
- 8.00
- EPS (trailing)
- $7.82
- EPS (forward)
- $9.96
- Dividend yield
- 0.26%
- Payout ratio
- 11.1%
- Ex-dividend date
- 2026-07-29
- 52-week range
- $223.83 – $386.00
- 52-week change
- 34.3%
- Beta
- 1.14
- Average volume
- 694,387
- Shares outstanding
- 70.4M
- Short % of float
- 3.53%
- Profit margin
- 17.0%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-11
In RapidTradeView’s 2026-09-11 scan of the US universe, West Pharmaceutical Services, Inc. (WST) last closed at $344.25 (the last completed close before that scan).
Technicals at the scan: RSI 50 (neutral territory), price -0.3% versus its 20-day average, 20-day versus 50-day average spread -1.1%, MACD histogram -0.68.
Sentiment inputs: 89% of recent Finnhub-scored headlines read bullish; analyst consensus score 76/100.
Next scheduled company event: in 41 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of WST; corporate insiders filed 0 buys and 3 sells (1 filer, latest disclosure 2026-09-10). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Annette F. Favorite (0B/3S). Who is trading what
RapidTradeView pick record
WST has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls West Pharmaceutical Services, Inc. (WST) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell WST.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.